WEBINAR: INNOVATIVE ENDPOINTS IN ALZHEIMER’S DISEASE CLINICAL TRIALS

Together with our partner Brain Research Center, we presented the webinar:

Innovative Endpoints in Alzheimer’s Disease Clinical Trials.

During this webinar, which has been hosted by Thea Wesseling, two experts in the field: Dr. Niels Prins and Dr. Jort Vijverberg gave their thoughts on how we advance clinical drug development for Alzheimer’s disease by touching upon:
> Biomarker-based participant selection in AD trials
> Fluid biomarkers as endpoints in AD trials
> EEG; a ‘novel’ AD biomarker

More information about Brain Research Center, you will find below.